DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Conditions
Breast Cancer · Breast Cancer Female · Metastatic Triple-Negative Breast Carcinoma · ER Positive Breast Cancer · HER2-negative Breast Cancer · HER2 Negative Breast Carcinoma · ER-negative Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Miami Baptist Cancer Institute/, Miami, Florida, United States
Manmeet Ahluwalia, MD (Sub-investigator)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Sarah Sammons, MD)Duke University Medical Center, Durham, North Carolina, United States
Study leads
Sarah Sammons, MD
Principal Investigator
Dana-Farber Cancer Institute